YK11 - Deus Medical

First identified in 2011 by Kanno et al., YK11 stands out as a steroidal SARM. Its design allows it to interact with androgen receptors differently from non-steroidal options. Acting as a partial activator, YK11 can trigger anabolic effects without the full range of androgenic side effects. It also boosts follistatin, a key regulator that blocks myostatin, aiding muscle growth. These traits have made it a topic of interest among those exploring new paths for physical development and performance.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about YK11 by Deus Medical, consult with your doctor or healthcare professional.